Symic Biomedical selects SBCV-030 as vascular clinical candidate
21 July 2015 | By Victoria White
Symic Biomedical has selected SBCV-030 as its vascular clinical candidate. SBCV-030 inhibits the scarring response that occurs when a vessel is injured...